Mustang Bio Statistics

Total Valuation

Mustang Bio has a market cap or net worth of $17.00 million. The enterprise value is $17.69 million.

Market Cap	17.00M
Enterprise Value	17.69M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, after market close.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Mustang Bio has 30.42 million shares outstanding. The number of shares has increased by 39.04% in one year.

Shares Outstanding	30.42M
Shares Change (YoY)	+39.04%
Shares Change (QoQ)	+12.28%
Owned by Insiders (%)	7.14%
Owned by Institutions (%)	2.53%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.53

Current Ratio	0.53
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.67

Financial Efficiency

Return on equity (ROE) is -1,243.20%.

Return on Equity (ROE)	-1,243.20%
Return on Assets (ROA)	-195.60%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$501,250
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.78% in the last 52 weeks. The beta is 1.70, so Mustang Bio's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	-90.78%
50-Day Moving Average	0.32
200-Day Moving Average	1.14
Relative Strength Index (RSI)	59.97
Average Volume (20 Days)	80,773,087

Short Selling Information

The latest short interest is 680,992, so 2.24% of the outstanding shares have been sold short.

Short Interest	680,992
Short Previous Month	2.33M
Short % of Shares Out	2.24%
Short % of Float	n/a
Short Ratio (days to cover)	0.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.17M
Pretax Income	-40.10M
Net Income	-40.10M
EBITDA	-35.10M
EBIT	-37.17M
Earnings Per Share (EPS)	-$4.40

Full Income Statement

Balance Sheet

The company has $1.71 million in cash and $2.40 million in debt, giving a net cash position of -$685,000 or -$0.02 per share.

Cash & Cash Equivalents	1.71M
Total Debt	2.40M
Net Cash	-685,000
Net Cash Per Share	-$0.02
Equity (Book Value)	-4.94M
Book Value Per Share	-0.16
Working Capital	-8.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.99 million and capital expenditures $5.94 million, giving a free cash flow of -$31.05 million.

Operating Cash Flow	-36.99M
Capital Expenditures	5.94M
Free Cash Flow	-31.05M
FCF Per Share	-$2.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mustang Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.04%
Shareholder Yield	-39.04%
Earnings Yield	-235.83%
FCF Yield	-182.63%

Analyst Forecast

The average price target for Mustang Bio is $12.00, which is 2,046.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	2,046.69%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 4, 2023. It was a reverse split with a ratio of 1:15.

Last Split Date	Apr 4, 2023
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	2